TCI Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
RCMU
CS
TCI Wealth Advisors's SGMO Position: Q2 2023 in Review
TCI Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 1,707 shares — an estimated $3K sold.
TCI Wealth Advisors first reported a position in SGMO in Q4 2017 and held it in 22 quarters. The position peaked at $44K in Q3 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.
- TCI Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 1,707 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $3K.
- TCI Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 22 quarters.
- TCI Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $44K in Q3 2018.
- 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.